Zhengye Biotechnology Holding Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZYBT research report →
Price Chart
About the company
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines.
- CEO
- Songlin Song
- IPO
- 2025
- Employees
- 269
- HQ
- Jilin, JI, CN
Get TickerSpark's AI analysis on ZYBT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $52.60M
- P/E
- -4.99
- PEG
- -0.05
- P/S
- 4.40
- P/B
- 1.41
- EV/EBITDA
- -9.10
- Div Yield
- 0.00%
- Gross Margin
- 8.30%
- Op Margin
- -77.04%
- Net Margin
- -89.05%
- ROE
- -26.78%
- ROIC
- -16.15%
Latest fiscal year · YoY change
- Revenue
- $116.36M-37.6%
- Gross Profit
- $23.87M-73.9%
- Op Income
- $-68,254,000
- Net Income
- $-69,784,000-717.0%
- EPS
- $-1.40-683.3%
- OCF Growth
- -67.5%
- FCF Growth
- -94.7%
- 52W High
- $8.01
- 52W Low
- $0.62
- 50D MA
- $1.55
- 200D MA
- $1.15
- Beta
- -2.29
- RSI (14)
- 35
- Avg Volume
- 5.19M
No earnings-call transcripts are available for ZYBT yet.
- Free Float
- 9.3%
- Shares Outstanding
- 47.39M
- Float Shares
- 4.43M
of shares held by institutions
8 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Xtx Topco Ltd | 48.87K | ▲ 4.72K |
| Geode Capital Management, LLC | 29.07K | 0 |
| Winton Group Ltd | 12.73K | ▼ 20.66K |
| Ubs Group AG | 7.99K | ▼ 44 |
| Royal Bank Of Canada | 1.23K | 0 |
| Morgan Stanley | 248 | ▼ 13 |
| Jpmorgan Chase & Co | 134 | ▲ 134 |
| Caitong International Asset Management Co., Ltd | 1 | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 25, 26 | Han Zhenfa | other | 0 |
| Jun 25, 26 | Han Zhenfa | other | 0 |
| Jun 25, 26 | Han Zhenfa | other | 0 |
| Jun 25, 26 | Cheng Yuhong (nmn) | other | 0 |
| Jun 25, 26 | Song Songlin | other | 0 |
| Jun 25, 26 | Wang Ping (nmn) | other | 0 |
| Jun 25, 26 | Jiang Ping (PiJi) | other | 0 |
| Mar 24, 26 | Hu Qiyi | other | 0 |
| Mar 24, 26 | Li Guohan (nmn) | other | 0 |
| Mar 18, 26 | Liu Zhongyao | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ZYBT coverage
Recent articles, reports, and earnings notes.
No research on ZYBT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ZYBT report →Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement
globenewswire.com · Aug 6
Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity
globenewswire.com · Jul 21
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
globenewswire.com · Jun 4
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
globenewswire.com · Jun 4
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results
prnewswire.com · Apr 28
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure
globenewswire.com · Apr 6
Short Interest in Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Declines By 36.7%
defenseworld.net · Mar 27
Zhengye Biotechnology Holding Limited Issues 2026 Chairman's Letter to Shareholders
globenewswire.com · Feb 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.